Structure

Physi-Chem Properties

Molecular Weight:  652.29
Volume:  652.838
LogP:  4.345
LogD:  2.062
LogS:  -5.351
# Rotatable Bonds:  11
TPSA:  155.64
# H-Bond Aceptor:  11
# H-Bond Donor:  1
# Rings:  6
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.306
Synthetic Accessibility Score:  6.367
Fsp3:  0.639
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.252
MDCK Permeability:  1.3945771570433863e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.036
Human Intestinal Absorption (HIA):  0.061
20% Bioavailability (F20%):  0.997
30% Bioavailability (F30%):  0.958

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.395
Plasma Protein Binding (PPB):  88.89136505126953%
Volume Distribution (VD):  2.246
Pgp-substrate:  6.776479721069336%

ADMET: Metabolism

CYP1A2-inhibitor:  0.068
CYP1A2-substrate:  0.495
CYP2C19-inhibitor:  0.91
CYP2C19-substrate:  0.366
CYP2C9-inhibitor:  0.953
CYP2C9-substrate:  0.012
CYP2D6-inhibitor:  0.13
CYP2D6-substrate:  0.022
CYP3A4-inhibitor:  0.966
CYP3A4-substrate:  0.773

ADMET: Excretion

Clearance (CL):  3.132
Half-life (T1/2):  0.172

ADMET: Toxicity

hERG Blockers:  0.455
Human Hepatotoxicity (H-HT):  0.761
Drug-inuced Liver Injury (DILI):  0.378
AMES Toxicity:  0.326
Rat Oral Acute Toxicity:  0.985
Maximum Recommended Daily Dose:  0.708
Skin Sensitization:  0.158
Carcinogencity:  0.739
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.971

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469633

Natural Product ID:  NPC469633
Common Name*:   Moluccensins H
IUPAC Name:   n.a.
Synonyms:   Moluccensins H
Standard InCHIKey:  RTUULIKPFWFGBC-RKVWQHKYSA-N
Standard InCHI:  InChI=1S/C36H44O11/c1-9-19(4)30(41)47-35-17-33(6)23(15-24(37)43-8)34(35,7)21-10-12-32(5)22(14-25(38)45-28(32)20-11-13-44-16-20)26(21)27(39)36(35,42)31(33)46-29(40)18(2)3/h11,13-14,16,18-19,23,28,31,42H,9-10,12,15,17H2,1-8H3/t19-,23-,28-,31-,32+,33-,34+,35+,36+/m0/s1
SMILES:  CCC(C)C(=O)OC12CC3(C(C1(C4=C(C5=CC(=O)OC(C5(CC4)C)C6=COC=C6)C(=O)C2(C3OC(=O)C(C)C)O)C)CC(=O)OC)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1094916
PubChem CID:   46211773
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[20112995]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[20146503]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds Thai n.a. PMID[21733687]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[22724531]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[26114936]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT4696 Organism Brontispa longissima Brontispa longissima Activity = 20.7 % PMID[468261]
NPT4696 Organism Brontispa longissima Brontispa longissima Activity = 27.6 % PMID[468261]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469633 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9938 High Similarity NPC469576
0.9693 High Similarity NPC94763
0.9573 High Similarity NPC236004
0.9341 High Similarity NPC478177
0.9329 High Similarity NPC327922
0.9222 High Similarity NPC471437
0.9202 High Similarity NPC165218
0.9152 High Similarity NPC478179
0.9091 High Similarity NPC478178
0.9006 High Similarity NPC470938
0.8929 High Similarity NPC472659
0.8876 High Similarity NPC159232
0.8876 High Similarity NPC285227
0.8869 High Similarity NPC472766
0.8869 High Similarity NPC472765
0.8851 High Similarity NPC242068
0.8851 High Similarity NPC247563
0.8841 High Similarity NPC472778
0.8841 High Similarity NPC472777
0.8841 High Similarity NPC472776
0.881 High Similarity NPC472764
0.881 High Similarity NPC476224
0.8802 High Similarity NPC469849
0.8795 High Similarity NPC329938
0.8772 High Similarity NPC471632
0.875 High Similarity NPC472141
0.875 High Similarity NPC470875
0.875 High Similarity NPC149945
0.8743 High Similarity NPC105395
0.8743 High Similarity NPC469338
0.8743 High Similarity NPC292389
0.8727 High Similarity NPC36655
0.8727 High Similarity NPC261597
0.8727 High Similarity NPC173544
0.872 High Similarity NPC214541
0.872 High Similarity NPC44675
0.8713 High Similarity NPC469848
0.8698 High Similarity NPC173516
0.869 High Similarity NPC276551
0.869 High Similarity NPC470940
0.8683 High Similarity NPC82851
0.8675 High Similarity NPC475226
0.8675 High Similarity NPC475967
0.8675 High Similarity NPC474932
0.8671 High Similarity NPC470181
0.8667 High Similarity NPC469485
0.8647 High Similarity NPC471397
0.8647 High Similarity NPC160651
0.8639 High Similarity NPC214600
0.8631 High Similarity NPC663
0.8631 High Similarity NPC224394
0.8631 High Similarity NPC472669
0.8623 High Similarity NPC470789
0.8623 High Similarity NPC472653
0.8623 High Similarity NPC477402
0.8614 High Similarity NPC187149
0.8614 High Similarity NPC470118
0.8606 High Similarity NPC264943
0.8596 High Similarity NPC470995
0.8588 High Similarity NPC472775
0.8588 High Similarity NPC472774
0.8571 High Similarity NPC472668
0.8571 High Similarity NPC470792
0.8571 High Similarity NPC472767
0.8571 High Similarity NPC471166
0.8571 High Similarity NPC471167
0.8571 High Similarity NPC6326
0.8571 High Similarity NPC188649
0.8571 High Similarity NPC69028
0.8571 High Similarity NPC149896
0.8563 High Similarity NPC477403
0.8563 High Similarity NPC472779
0.8555 High Similarity NPC477824
0.8538 High Similarity NPC472652
0.8538 High Similarity NPC271235
0.8521 High Similarity NPC288602
0.8521 High Similarity NPC472773
0.8521 High Similarity NPC472139
0.8521 High Similarity NPC88841
0.8521 High Similarity NPC471168
0.8521 High Similarity NPC477405
0.8503 High Similarity NPC197137
0.8503 High Similarity NPC299038
0.8503 High Similarity NPC45101
0.8503 High Similarity NPC249021
0.8503 High Similarity NPC195131
0.8494 Intermediate Similarity NPC155939
0.8494 Intermediate Similarity NPC296807
0.8494 Intermediate Similarity NPC141538
0.8488 Intermediate Similarity NPC472650
0.8485 Intermediate Similarity NPC44577
0.848 Intermediate Similarity NPC472282
0.848 Intermediate Similarity NPC472651
0.8471 Intermediate Similarity NPC470182
0.8471 Intermediate Similarity NPC259943
0.8471 Intermediate Similarity NPC271657
0.8462 Intermediate Similarity NPC472771
0.8462 Intermediate Similarity NPC18347
0.8462 Intermediate Similarity NPC197596
0.8462 Intermediate Similarity NPC200782
0.8462 Intermediate Similarity NPC5079
0.8462 Intermediate Similarity NPC5741
0.8452 Intermediate Similarity NPC307383
0.8452 Intermediate Similarity NPC472671
0.8443 Intermediate Similarity NPC204663
0.8439 Intermediate Similarity NPC475237
0.8439 Intermediate Similarity NPC475641
0.8439 Intermediate Similarity NPC160818
0.8439 Intermediate Similarity NPC169299
0.8434 Intermediate Similarity NPC253201
0.8434 Intermediate Similarity NPC302054
0.843 Intermediate Similarity NPC472673
0.8412 Intermediate Similarity NPC469846
0.8412 Intermediate Similarity NPC51568
0.8412 Intermediate Similarity NPC302369
0.8412 Intermediate Similarity NPC134254
0.8412 Intermediate Similarity NPC39986
0.8412 Intermediate Similarity NPC234660
0.8402 Intermediate Similarity NPC191828
0.8402 Intermediate Similarity NPC25255
0.8393 Intermediate Similarity NPC214495
0.8393 Intermediate Similarity NPC472283
0.8393 Intermediate Similarity NPC475066
0.8393 Intermediate Similarity NPC470119
0.8393 Intermediate Similarity NPC286722
0.8393 Intermediate Similarity NPC167142
0.8393 Intermediate Similarity NPC88007
0.8383 Intermediate Similarity NPC476262
0.8383 Intermediate Similarity NPC92979
0.8382 Intermediate Similarity NPC82602
0.8373 Intermediate Similarity NPC33938
0.8373 Intermediate Similarity NPC472672
0.8373 Intermediate Similarity NPC476201
0.8373 Intermediate Similarity NPC469503
0.8373 Intermediate Similarity NPC246164
0.8372 Intermediate Similarity NPC476850
0.8372 Intermediate Similarity NPC476861
0.8364 Intermediate Similarity NPC470997
0.8363 Intermediate Similarity NPC476856
0.8363 Intermediate Similarity NPC476858
0.8363 Intermediate Similarity NPC476857
0.8363 Intermediate Similarity NPC123088
0.8353 Intermediate Similarity NPC68848
0.8353 Intermediate Similarity NPC193798
0.8353 Intermediate Similarity NPC263432
0.8343 Intermediate Similarity NPC473473
0.8343 Intermediate Similarity NPC475295
0.8333 Intermediate Similarity NPC209364
0.8333 Intermediate Similarity NPC175964
0.8333 Intermediate Similarity NPC471169
0.8324 Intermediate Similarity NPC296558
0.8323 Intermediate Similarity NPC237259
0.8323 Intermediate Similarity NPC282445
0.8323 Intermediate Similarity NPC30222
0.8323 Intermediate Similarity NPC98206
0.8323 Intermediate Similarity NPC34421
0.8314 Intermediate Similarity NPC121995
0.8313 Intermediate Similarity NPC116717
0.8313 Intermediate Similarity NPC18135
0.8304 Intermediate Similarity NPC285567
0.8303 Intermediate Similarity NPC471001
0.8303 Intermediate Similarity NPC69647
0.8303 Intermediate Similarity NPC472654
0.8303 Intermediate Similarity NPC125182
0.8303 Intermediate Similarity NPC234494
0.8294 Intermediate Similarity NPC335761
0.8293 Intermediate Similarity NPC255414
0.8284 Intermediate Similarity NPC472772
0.8284 Intermediate Similarity NPC195954
0.8284 Intermediate Similarity NPC194499
0.8284 Intermediate Similarity NPC469847
0.8274 Intermediate Similarity NPC471175
0.8274 Intermediate Similarity NPC35000
0.8274 Intermediate Similarity NPC469336
0.8266 Intermediate Similarity NPC476853
0.8266 Intermediate Similarity NPC100333
0.8263 Intermediate Similarity NPC182427
0.8263 Intermediate Similarity NPC268905
0.8263 Intermediate Similarity NPC470996
0.8263 Intermediate Similarity NPC29695
0.8263 Intermediate Similarity NPC308205
0.8263 Intermediate Similarity NPC322546
0.8256 Intermediate Similarity NPC261184
0.8256 Intermediate Similarity NPC476860
0.8253 Intermediate Similarity NPC196846
0.8253 Intermediate Similarity NPC156189
0.8246 Intermediate Similarity NPC117986
0.8246 Intermediate Similarity NPC470939
0.8246 Intermediate Similarity NPC211777
0.8246 Intermediate Similarity NPC290400
0.8246 Intermediate Similarity NPC18986
0.8246 Intermediate Similarity NPC96443
0.8229 Intermediate Similarity NPC294512
0.8225 Intermediate Similarity NPC107646
0.8225 Intermediate Similarity NPC126723
0.8214 Intermediate Similarity NPC57998
0.8214 Intermediate Similarity NPC178932
0.8208 Intermediate Similarity NPC472670
0.8208 Intermediate Similarity NPC23387
0.8208 Intermediate Similarity NPC475779

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469633 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8494 Intermediate Similarity NPD5761 Phase 2
0.8494 Intermediate Similarity NPD5760 Phase 2
0.8268 Intermediate Similarity NPD8434 Phase 2
0.8081 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7889 Intermediate Similarity NPD6764 Approved
0.7889 Intermediate Similarity NPD6765 Approved
0.7717 Intermediate Similarity NPD6785 Approved
0.7717 Intermediate Similarity NPD6784 Approved
0.7377 Intermediate Similarity NPD7799 Discontinued
0.734 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7247 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7075 Discontinued
0.722 Intermediate Similarity NPD8404 Phase 2
0.7175 Intermediate Similarity NPD6599 Discontinued
0.7151 Intermediate Similarity NPD7819 Suspended
0.7128 Intermediate Similarity NPD7685 Pre-registration
0.7111 Intermediate Similarity NPD3817 Phase 2
0.7095 Intermediate Similarity NPD6801 Discontinued
0.7088 Intermediate Similarity NPD919 Approved
0.7069 Intermediate Similarity NPD7236 Approved
0.7037 Intermediate Similarity NPD6559 Discontinued
0.7011 Intermediate Similarity NPD8127 Discontinued
0.7006 Intermediate Similarity NPD920 Approved
0.6974 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6966 Remote Similarity NPD7239 Suspended
0.6965 Remote Similarity NPD7497 Discontinued
0.6954 Remote Similarity NPD4628 Phase 3
0.6943 Remote Similarity NPD8150 Discontinued
0.6935 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6932 Remote Similarity NPD6799 Approved
0.6923 Remote Similarity NPD5402 Approved
0.6919 Remote Similarity NPD1247 Approved
0.6915 Remote Similarity NPD3818 Discontinued
0.6893 Remote Similarity NPD642 Clinical (unspecified phase)
0.6885 Remote Similarity NPD3882 Suspended
0.6878 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6865 Remote Similarity NPD5494 Approved
0.6862 Remote Similarity NPD7473 Discontinued
0.6854 Remote Similarity NPD6273 Approved
0.6839 Remote Similarity NPD8407 Phase 2
0.6828 Remote Similarity NPD7199 Phase 2
0.6816 Remote Similarity NPD5403 Approved
0.6798 Remote Similarity NPD5401 Approved
0.6798 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6796 Remote Similarity NPD4380 Phase 2
0.6793 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6782 Remote Similarity NPD5763 Approved
0.6782 Remote Similarity NPD5762 Approved
0.678 Remote Similarity NPD643 Clinical (unspecified phase)
0.6776 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6771 Remote Similarity NPD8368 Discontinued
0.6761 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6761 Remote Similarity NPD7907 Approved
0.6757 Remote Similarity NPD3749 Approved
0.6757 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6739 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6736 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6736 Remote Similarity NPD7808 Phase 3
0.6721 Remote Similarity NPD1934 Approved
0.672 Remote Similarity NPD6168 Clinical (unspecified phase)
0.672 Remote Similarity NPD6166 Phase 2
0.672 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6719 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6704 Remote Similarity NPD2534 Approved
0.6704 Remote Similarity NPD2532 Approved
0.6704 Remote Similarity NPD2533 Approved
0.6703 Remote Similarity NPD7028 Phase 2
0.6702 Remote Similarity NPD6232 Discontinued
0.6702 Remote Similarity NPD5844 Phase 1
0.6701 Remote Similarity NPD8313 Approved
0.6701 Remote Similarity NPD8312 Approved
0.6701 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6002 Phase 3
0.6686 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6686 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6686 Remote Similarity NPD6004 Phase 3
0.6686 Remote Similarity NPD6005 Phase 3
0.6685 Remote Similarity NPD2801 Approved
0.6684 Remote Similarity NPD7251 Discontinued
0.6667 Remote Similarity NPD3926 Phase 2
0.6667 Remote Similarity NPD7411 Suspended
0.6649 Remote Similarity NPD3751 Discontinued
0.6648 Remote Similarity NPD3226 Approved
0.6632 Remote Similarity NPD6797 Phase 2
0.6631 Remote Similarity NPD6234 Discontinued
0.6629 Remote Similarity NPD2796 Approved
0.662 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6615 Remote Similarity NPD7054 Approved
0.6613 Remote Similarity NPD7057 Phase 3
0.6613 Remote Similarity NPD4966 Approved
0.6613 Remote Similarity NPD7058 Phase 2
0.6613 Remote Similarity NPD4965 Approved
0.6613 Remote Similarity NPD4967 Phase 2
0.6611 Remote Similarity NPD7004 Clinical (unspecified phase)
0.661 Remote Similarity NPD1243 Approved
0.661 Remote Similarity NPD2800 Approved
0.6591 Remote Similarity NPD1471 Phase 3
0.659 Remote Similarity NPD6355 Discontinued
0.6589 Remote Similarity NPD4665 Approved
0.6589 Remote Similarity NPD4111 Phase 1
0.658 Remote Similarity NPD7472 Approved
0.658 Remote Similarity NPD7074 Phase 3
0.6575 Remote Similarity NPD1512 Approved
0.6573 Remote Similarity NPD3750 Approved
0.6554 Remote Similarity NPD970 Clinical (unspecified phase)
0.6553 Remote Similarity NPD7435 Discontinued
0.6545 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6541 Remote Similarity NPD37 Approved
0.6533 Remote Similarity NPD8361 Approved
0.6533 Remote Similarity NPD8435 Approved
0.6533 Remote Similarity NPD8360 Approved
0.6526 Remote Similarity NPD3787 Discontinued
0.6524 Remote Similarity NPD7768 Phase 2
0.6519 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6517 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6497 Remote Similarity NPD2346 Discontinued
0.6494 Remote Similarity NPD5735 Approved
0.6488 Remote Similarity NPD4107 Approved
0.6477 Remote Similarity NPD7033 Discontinued
0.6477 Remote Similarity NPD2799 Discontinued
0.6477 Remote Similarity NPD3748 Approved
0.6477 Remote Similarity NPD7228 Approved
0.6477 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6474 Remote Similarity NPD6959 Discontinued
0.6471 Remote Similarity NPD5647 Approved
0.6467 Remote Similarity NPD7458 Discontinued
0.6464 Remote Similarity NPD1511 Approved
0.6461 Remote Similarity NPD1549 Phase 2
0.6457 Remote Similarity NPD6653 Approved
0.6456 Remote Similarity NPD4482 Phase 3
0.6448 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6445 Remote Similarity NPD7874 Approved
0.6445 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6441 Remote Similarity NPD6099 Approved
0.6441 Remote Similarity NPD1551 Phase 2
0.6441 Remote Similarity NPD6100 Approved
0.6425 Remote Similarity NPD3057 Approved
0.6425 Remote Similarity NPD3533 Approved
0.6425 Remote Similarity NPD2972 Approved
0.6422 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6417 Remote Similarity NPD1465 Phase 2
0.6416 Remote Similarity NPD2313 Discontinued
0.6408 Remote Similarity NPD6780 Approved
0.6408 Remote Similarity NPD6781 Approved
0.6408 Remote Similarity NPD6776 Approved
0.6408 Remote Similarity NPD6779 Approved
0.6408 Remote Similarity NPD6782 Approved
0.6408 Remote Similarity NPD6777 Approved
0.6408 Remote Similarity NPD6778 Approved
0.6404 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6404 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6394 Remote Similarity NPD7696 Phase 3
0.6394 Remote Similarity NPD7698 Approved
0.6394 Remote Similarity NPD7697 Approved
0.6384 Remote Similarity NPD1510 Phase 2
0.6379 Remote Similarity NPD8032 Phase 2
0.6374 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6373 Remote Similarity NPD2403 Approved
0.6372 Remote Similarity NPD7048 Phase 3
0.6364 Remote Similarity NPD8320 Phase 1
0.6364 Remote Similarity NPD8319 Approved
0.6364 Remote Similarity NPD7871 Phase 2
0.6364 Remote Similarity NPD7870 Phase 2
0.6359 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6354 Remote Similarity NPD7315 Approved
0.6354 Remote Similarity NPD6190 Approved
0.6354 Remote Similarity NPD7229 Phase 3
0.6351 Remote Similarity NPD7701 Phase 2
0.635 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6346 Remote Similarity NPD2491 Approved
0.6345 Remote Similarity NPD7240 Approved
0.6343 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6343 Remote Similarity NPD4140 Approved
0.6341 Remote Similarity NPD8485 Approved
0.6338 Remote Similarity NPD7801 Approved
0.6322 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6313 Remote Similarity NPD2344 Approved
0.6308 Remote Similarity NPD8462 Phase 1
0.6307 Remote Similarity NPD447 Suspended
0.6301 Remote Similarity NPD6832 Phase 2
0.6298 Remote Similarity NPD4110 Phase 3
0.6298 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6298 Remote Similarity NPD8166 Discontinued
0.6298 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6294 Remote Similarity NPD7078 Approved
0.629 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6289 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6286 Remote Similarity NPD6663 Approved
0.6284 Remote Similarity NPD6143 Clinical (unspecified phase)
0.628 Remote Similarity NPD8285 Discontinued
0.6271 Remote Similarity NPD6651 Approved
0.6271 Remote Similarity NPD6353 Approved
0.6269 Remote Similarity NPD5711 Approved
0.6269 Remote Similarity NPD5710 Approved
0.6268 Remote Similarity NPD3448 Approved
0.6264 Remote Similarity NPD7095 Approved
0.6262 Remote Similarity NPD5676 Approved
0.6257 Remote Similarity NPD2935 Discontinued
0.625 Remote Similarity NPD7930 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data